Dr. Michael Dulin, Chief Medical Officer with data analytics business Tresata who also works as a family physician, shared his experience of genetic testing at the HIMSS Precision Medicine Summit in Boston this week.
Although the use of mobile technology in healthcare is growing more common, numerous obstacles still block the way to widespread adoption.
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.
There's only so much HIMSS conference a publication like MedCity News can cover, so it's impossible to know everything that has gone on here in Orlando, but let's give it our best shot.
After 15 years of research, Patrick Soon-Shiong has unveiled the Nant Cancer Vaccine, bringing together myriad biology and technology advances made throughout his NantWorks empire.
HIMSS CEO Steve Lieber, who is retiring at the end of 2017, is preparing to depart at a time when health IT at a crossroads.
The only known treatments for #HIMSSanity are an extended weekend off after HIMSS, a couple of nights out during the event and, of course, a lot of laughter.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
There has been a ton of progress in health IT since Steve Lieber took the reins of HIMSS in 2000, but there is so much work left to be done.
Steve Lieber has shepherded HIMSS through a period of rapid growth in size and clout during his 17-year tenure. The organization has begun a search for a successor.
As the Connected Health Conference — formerly known as the mHealth Summit — gets underway in National Harbor, Maryland, the organization that puts it on, the Personal Connected Health Alliance, is taking part in a merger of sorts.
The ROI we anticipate through this inclusion process could translate into material patient presence on corporate boards, steering committees, advisory councils, product management focus groups, and beyond.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Ever feel overmatched? That's how our reporter felt at HIMSS16 in Las Vegas last week when he did a video — streamed live online by HealthIT.TV — with athenahealth CEO Jonathan Bush and Dr. Zubin "ZDoggMD" Damania.
In an interview at HIMSS, QPID Health CEO Mike Doyle talked about how the deal went down.
Peyton Manning packed the house, perhaps because people were hoping he might announce his retirement in the unlikely venue of HIMSS16. Manning didn't discuss his football plans, though he sounded like someone who still wants to play.
A simple question (followed by a shameless plug): What will we see from HIMSS culminate in real action the rest of the year? An embrace of secure patient portals? Interoperability policies turned into action? Meaningful progress on providers ready for pay-for-value? Better EMRs? So many discussions at HIMSS. To get a better gauge on what […]
CEO Debra Reisenthel secured approval from the U.S. Food and Drug Administration in 2013 for an app that functions like a digital drug to help get breathing under control for the 2.7 percent of the U.S. population who suffer from panic disorder.